BIOMAT Database Logo BIOMAT Database Logo

Relapses in patients with myasthenia gravis treated with azathioprine. 1993

R Wilensky, and B Dwyer, and R F Mayer
Department of Neurology, University of Maryland School of Medicine, Baltimore 21201.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R Wilensky, and B Dwyer, and R F Mayer
Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients.
October 2015, Brain and behavior,
R Wilensky, and B Dwyer, and R F Mayer
The course of myasthenia gravis in patients treated with corticosteroids, azathioprine, and plasmapheresis.
January 1987, Annals of the New York Academy of Sciences,
R Wilensky, and B Dwyer, and R F Mayer
Azathioprine and myasthenia gravis.
October 1987, Lancet (London, England),
R Wilensky, and B Dwyer, and R F Mayer
Azathioprine for myasthenia gravis.
June 1972, Lancet (London, England),
R Wilensky, and B Dwyer, and R F Mayer
Cytomegalovirus-associated hemophagocytic lymphohistiocytosis in a patient with myasthenia gravis treated with azathioprine.
April 2014, Blood,
R Wilensky, and B Dwyer, and R F Mayer
Hypersensitivity to azathioprine in myasthenia gravis.
May 1984, Postgraduate medical journal,
R Wilensky, and B Dwyer, and R F Mayer
Monitoring azathioprine therapy in myasthenia gravis.
November 1986, Neurology,
R Wilensky, and B Dwyer, and R F Mayer
Long term treatment of myasthenia gravis with azathioprine.
February 1990, Postgraduate medical journal,
R Wilensky, and B Dwyer, and R F Mayer
Azathioprine in the treatment of myasthenia gravis.
June 1984, Annals of neurology,
R Wilensky, and B Dwyer, and R F Mayer
Myasthenia gravis: discontinuation of long-term azathioprine.
December 1988, Annals of neurology,
Copied contents to your clipboard!